Safety and efficacy of grazoprevir/elbasvir in the treatment of acute hepatitis C in hemodialysis patients

Treatment of hepatitis C virus (HCV) infection with direct‐acting antiviral agents (DAAs) in hemodialysis patients requires extensive consideration. At present, studies regarding DAAs for acute HCV infection in such patients are limited. The present study aims to evaluate the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Qinghua, Chu, Xudong, Zhou, Yugui, Liu, Xuan, Zhao, Wei, Ye, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298284/
https://www.ncbi.nlm.nih.gov/pubmed/34599755
http://dx.doi.org/10.1002/jmv.27374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298284/
https://www.ncbi.nlm.nih.gov/pubmed/34599755
http://dx.doi.org/10.1002/jmv.27374

Ejemplares similares